excellence. About the Role WSAC is seeking an Operations Coordinator to oversee our diverse range of facilities. As the... Operations Coordinator, you will play a pivotal role in the continued success of WSAC. Your responsibilities will include...
and families across Australia. Currently seeking for a Disability Support Coordinator to join their busy team for 9 month temporary... assignment until end of December 2025 About the role As a Disability Support Coordinator, you will provide operational...
and families across Australia. Currently seeking for a Disability Support Coordinator to join their busy team for 9 month temporary... assignment until end of December 2025 About the role As a Disability Support Coordinator, you will provide operational...
by offending. The role of a Children's Court Youth Diversion Coordinator As a CCYD Coordinator, you will ensure children... coordinator attends scheduled sittings of the Criminal Division of the Children's Court to: conduct same-day assessments...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »